Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich protein BstNI subfamily 2 (PRB2) encodes a member of the basic, proline-rich human salivary glycoprotein family[1][5][7]. The preproprotein is proteolytically processed to produce one or more mature isoforms that are secreted by the parotid glands into saliva[1][2][7]. PRB2 contributes to the highly repetitive, proline-rich composition of saliva, playing roles in oral lubrication, formation of the protective acquired enamel pellicle, and binding of dietary polyphenols, which reduces their astringency and toxicity in the oral cavity[2][7][9]. The gene is polymorphic, with different alleles showing variable numbers of tandem repeats. PRB2 is not considered a classical drug target, receptor, enzyme, transporter, or transcription factor, and no clinically actionable therapeutics are known to interact with it[1][5][7]. Its expression is primarily relevant to oral biology, and while it has been reported in some cancer expression and mutation datasets, it is not established as a disease driver or biomarker[1][5][7].
Not applicable (not a therapeutic target, no known drug interactions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich protein BstNI subfamily 2 (PRB2).